Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its enquiry of ANA773, a Toll-Like Receptor-7 character prodrug. Approaching the Hepatitis C virus differently from most another contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load fall associated…